Bayesian Capital Management’s Cano Health, Inc. CANO Stock Holding History

Bayesian Capital Management’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,341	Closed	-$122K	–	1140
2023 Q1	$122K	Buy	+1,341	New	+$182K	0.02%	666
2022 Q3	–	Sell	-799	Closed	-$350K	–	1090
2022 Q2	$350K	Buy	799 +573	+254%	+$299K	0.07%	429
2022 Q1	$143K	Sell	226 -104	-32%	-$65.6K	0.02%	678
2021 Q4	$294K	Buy	+330	New	+$347K	0.09%	258

Other funds holding CANO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Diameter Capital Partners New York $1.24B AUM 137.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bayesian Capital Management's CANO Position: Q2 2023 in Review

Bayesian Capital Management sold out of Cano Health, Inc. (CANO) in Q2 2023, closing a stake of 1,341 shares — an estimated $122K sold.

Bayesian Capital Management first reported a position in CANO in Q4 2021 and held it in 4 quarters. The position peaked at $350K in Q2 2022. 154 funds tracked by Wall St. Rank hold CANO as of Q2 2023.

Bayesian Capital Management reported no remaining Cano Health, Inc. position as of Q2 2023 after selling out during the quarter.
Bayesian Capital Management sold 1,341 Cano Health, Inc. shares in Q2 2023, an estimated $122K.
Bayesian Capital Management first reported a position in Cano Health, Inc. in Q4 2021 and held it in 4 quarters.
Bayesian Capital Management's Cano Health, Inc. position peaked at $350K in Q2 2022.
154 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2023.

Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.